A firm’s creation of proprietary knowledge linked to the knowledge spilled over from its research publications: the case of artificial intelligence

This study investigates the mechanism by which knowledge spilled over from a firm’s research publication consequently spills into the focal firm as a form of proprietary knowledge when it is engaged in an emerging science-related technology. We define the knowledge spillover pool (KSP) as an evolving group of papers citing a paper published by a firm. Focusing on the recent development of artificial intelligence, on which firms have published actively, we compare the KSP conditions related to the increase in patents created by the focal firm with those created by external actors. Using a Cox regression and subsequent contrast test, we find that both an increasing KSP and an increasing similarity between the idea published by the focal firm and KSP are positively related to the proprietary knowledge creation of both the focal firm and external actors, with such relations being significantly stronger for the focal firm than for external actors. On the contrary, an increasing proportion of industry papers in the KSP are positively associated with the proprietary knowledge creation not only by the focal firm but also by external actors to a similar degree. We contribute to the literature on selective revealing and to the firms’ publishing strategies

Firms’ influence on the evolution of published knowledge when a science-related technology emerges: The case of artificial intelligence

YesFirms with the assets complementary to Artificial Intelligence (AI) have actively conducted AI research and selectively published their results since AI has resurged around 2006. Focusing on the recent AI development, we investigate how and to what extent firms’ deep engagement in the publication of emerging science-related technology can influence the evolution of published knowledge. Using bibliometric analyses applied to the papers in major AI conferences and journals, we find that papers with at least one author affiliated to a firm, and particularly papers with only firm-affiliated author(s), have had higher influence on the formation of published knowledge trajectory than other papers. In addition, papers from firm and non-firm (university and public research institution) collaborations show higher novelty and conventionality than other papers. These findings deepen our understanding of the role of firms in the evolution of emerging science-related technology.This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2020R1A2C2005026)

A common variant near TGFBR3 is associated with primary open angle glaucoma

Primary open angle glaucoma (POAG), a major cause of blindness worldwide, is a complex disease with a significant genetic contribution. We performed Exome Array (Illumina) analysis on 3504 POAG cases and 9746 controls with replication of the most significant findings in 9173 POAG cases and 26 780 controls across 18 collections of Asian, African and European descent. Apart from confirming strong evidence of association at CDKN2B-AS1 (rs2157719 [G], odds ratio [OR] = 0.71, P = 2.81 × 10−33), we observed one SNP showing significant association to POAG (CDC7–TGFBR3 rs1192415, ORG-allele = 1.13, Pmeta = 1.60 × 10−8). This particular SNP has previously been shown to be strongly associated with optic disc area and vertical cup-to-disc ratio, which are regarded as glaucoma-related quantitative traits. Our study now extends this by directly implicating it in POAG disease pathogenesis

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Breast cancer risk genes: association analysis in more than 113,000 women

BACKGROUNDGenetic testing for breast cancer susceptibility is widely used, but for many genes, evidence of an association with breast cancer is weak, underlying risk estimates are imprecise, and reliable subtype-specific risk estimates are lacking.METHODSWe used a panel of 34 putative susceptibility genes to perform sequencing on samples from 60,466 women with breast cancer and 53,461 controls. In separate analyses for protein-truncating variants and rare missense variants in these genes, we estimated odds ratios for breast cancer overall and tumor subtypes. We evaluated missense-variant associations according to domain and classification of pathogenicity.RESULTSProtein-truncating variants in 5 genes (ATM, BRCA1, BRCA2, CHEK2, and PALB2) were associated with a risk of breast cancer overall with a P value of less than 0.0001. Protein-truncating variants in 4 other genes (BARD1, RAD51C, RAD51D, and TP53) were associated with a risk of breast cancer overall with a P value of less than 0.05 and a Bayesian false-discovery probability of less than 0.05. For protein-truncating variants in 19 of the remaining 25 genes, the upper limit of the 95% confidence interval of the odds ratio for breast cancer overall was less than 2.0. For protein-truncating variants in ATM and CHEK2, odds ratios were higher for estrogen receptor (ER)-positive disease than for ER-negative disease; for protein-truncating variants in BARD1, BRCA1, BRCA2, PALB2, RAD51C, and RAD51D, odds ratios were higher for ER-negative disease than for ER-positive disease. Rare missense variants (in aggregate) in ATM, CHEK2, and TP53 were associated with a risk of breast cancer overall with a P value of less than 0.001. For BRCA1, BRCA2, and TP53, missense variants (in aggregate) that would be classified as pathogenic according to standard criteria were associated with a risk of breast cancer overall, with the risk being similar to that of protein-truncating variants.CONCLUSIONSThe results of this study define the genes that are most clinically useful for inclusion on panels for the prediction of breast cancer risk, as well as provide estimates of the risks associated with protein-truncating variants, to guide genetic counseling. (Funded by European Union Horizon 2020 programs and others.)Molecular tumour pathology - and tumour geneticsMTG1 - Moleculaire genetica en pathologie van borstkanke

An Investigation of the Statistical Relationship between the 345 kv Transmission Line Length and the Outage Rate

The article of record as published may be found at https://doi.org/10.1142/S0218539394000088Finding the factors that are related to varying transmission outage rates has been one of the major concerns of the reliability practitioners in the electric power industry. One of the potentially influential factors is the length of the transmission line. In this paper, a random effects Poisson regression model is used to quantify the relationship between the outage rate to the transmission line length. The method suggested is applied to analyze two sets of the 345 KV transmission line outage data of the Commonwealth Edison Company: group 1 contains transmission lines that had been installed before January 1974; group 2 consists of the lines that have been installed since January 1974. Results indicate that in both cases there is a significant log linear relationship between the transmission line outage and the line length. However, the annual outage rate elasticity of transmission lines of group 2 turns to be 0.33 while that of group 1 is 0.64. This would imply apparent quality improvement on the transmission lines in group 2

A Firm’s Creation of Proprietary Knowledge Linked to the Knowledge Spilled Over from its Research Publications: The Case of Artificial Intelligence

YesThis study investigates the mechanism by which knowledge spilled over from a firm’s research publication consequently spills into the focal firm as a form of proprietary knowledge when it is engaged in an emerging science-related technology. We define the knowledge spillover pool (KSP) as an evolving group of papers citing a paper published by a firm. Focusing on the recent development of artificial intelligence, on which firms have published actively, we compare the KSP conditions related to the increase in patents created by the focal firm with those created by external actors. Using a Cox regression and subsequent contrast test, we find that both an increasing KSP and an increasing similarity between the idea published by the focal firm and KSP are positively related to the proprietary knowledge creation of both the focal firm and external actors, with such relations being significantly stronger for the focal firm than for external actors. On the contrary, an increasing proportion of industry papers in the KSP is positively associated with the proprietary knowledge creation not only by the focal firm but also by external actors to a similar degree. We contribute to the literature on selective revealing and to the firms’ publishing strategies.The full text will be available at the end of the publisher's embargo: 20th May 202